-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Axogen, Raises Price Target to $65

Benzinga·11/19/2026 19:22:26
Listen to the news
Leerink Partners analyst Mike Kratky maintains Axogen (NASDAQ:AXGN) with a Outperform and raises the price target from $56 to $65.